Who owns NEUMORA THERAPEUTICS INC.?
- Ticker: NMRA
- CUSIP Number: 640979100
Tip: Access positions for across all investors
Analyze quarterly positions in Neumora Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neumora Therapeutics stock
Who bought or sold NEUMORA THERAPEUTICS INC. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Softbank Group Corp | 7.6M | $130M | 0% | Dec 2023 |
|
| MIC Capital Management UK | 4.5M | $76M | 0% | Dec 2023 |
|
| Wellcome Trust Limited, as Trustee of the Wellcome Trust | 3.3M | $46M | 0% | Mar 2024 |
|
| Artal Group | 2.6M | $44M | -9% | Dec 2023 |
|
| EcoR1 Capital | 2.1M | $35M | 0% | Dec 2023 |
|
| Avidity Partners Management | 2.0M | $34M | 11% | Dec 2023 |
|
| Citadel Advisors | 1.8M | $32M | -15% | Dec 2023 |
|
| Hillhouse Capital Advisors | 1.7M | $29M | 0% | Dec 2023 |
|
| OrbiMed Advisors | 1.5M | $26M | 0% | Dec 2023 |
|
| Goldman Sachs Group | 592k | $10M | 705% | Dec 2023 |
|
| Alphabet | 405k | $6.9M | 103% | Dec 2023 |
|
| Logos Global Management | 382k | $6.5M | 100% | Dec 2023 |
|
| Vanguard Group | 381k | $6.5M | 662% | Dec 2023 |
|
| Addis & Hill | 315k | $4.2M | 100% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 263k | $4.5M | 100% | Dec 2023 |
|
| GMT Capital Corp | 141k | $2.4M | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 130k | $2.2M | 100% | Dec 2023 |
|
| Scoggin | 125k | $2.1M | -17% | Dec 2023 |
|
| ALPS Advisors | 106k | $1.8M | 100% | Dec 2023 |
|
| Cormorant Asset Management | 92k | $1.6M | 0% | Dec 2023 |
|
| Jane Street | 89k | $1.5M | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 61k | $1.0M | 100% | Dec 2023 |
|
| Norges Bank Investment Management | 50k | $853k | 100% | Dec 2023 |
|
| GSA Capital Partners | 47k | $799k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 41k | $564k | -9% | Mar 2024 |
|
| Wells Fargo & Company | 27k | $466k | 100% | Dec 2023 |
|
| Windmill Hill Asset Management | 26k | $359k | 100% | Mar 2024 |
|
| Barclays | 21k | $350k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 16k | $268k | 100% | Dec 2023 |
|
| Bank of America Corporation | 15k | $258k | 100% | Dec 2023 |
|
| Wealth Enhancement Advisory Services | 13k | $173k | 100% | Mar 2024 |
|
| Legacy Private Trust | 10k | $138k | 0% | Mar 2024 |
|
| MetLife Investment Advisors | 8.5k | $145k | 100% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 8.0k | $137k | 100% | Dec 2023 |
|
| American International | 7.4k | $126k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.9k | $118k | 100% | Dec 2023 |
|
| Virtus ETF Advisers | 6.3k | $108k | 100% | Dec 2023 |
|
| SG Americas Securities | 6.3k | $108k | 100% | Dec 2023 |
|
| Citigroup | 5.7k | $98k | -60% | Dec 2023 |
|
| Royal Bank of Canada | 4.9k | $84k | -75% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.2k | $54k | 100% | Dec 2023 |
|
| Simplex Trading | 2.8k | $39k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 1.5k | $26k | 100% | Dec 2023 |
|
| Legal & General Group | 1.4k | $24k | -86% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 921.00 | $16k | 100% | Dec 2023 |
|
| Amalgamated Bank | 508.00 | $7.0k | -70% | Mar 2024 |
|
| UBS Group | 256.00 | $4.4k | 100% | Dec 2023 |
|
| Advisory Services Network | 200.00 | $3.4k | 100% | Dec 2023 |
|
| Quarry | 50.00 | $853.000000 | 100% | Dec 2023 |
|
| GAMMA Investing | 9.00 | $124.000200 | 100% | Mar 2024 |
|
| CWM | 3.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Neumora Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Sep 2023 | 275k | $3.9M |
| Marshall Wace | Sep 2023 | 256k | $3.6M |
| Two Sigma Investments | Sep 2023 | 59k | $825k |
| Point72 Middle East FZE | Sep 2023 | 44k | $617k |
| Laurion Capital Management | Sep 2023 | 22k | $304k |
| Zimmer Partners | Sep 2023 | 13k | $176k |
| Soros Fund Management | Sep 2023 | 10k | $141k |